P
THQ

&Partners’s abrdn Healthcare Opportunities Fund THQ Stock Holding History

&Partners’s Portfolio THQ Stock Details THQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$473K Buy
28,131
+5,993
+27% +$113K ﹤0.01% 1729
2025
Q4 		$424K Buy
22,138
+1,390
+7% +$25.5K ﹤0.01% 1722
2025
Q3 		$359K Buy
20,748
+584
+3% +$9.95K ﹤0.01% 1651
2025
Q2 		$371K Buy
20,164
+1,870
+10% +$34.7K ﹤0.01% 1511
2025
Q1 		$374K Buy
18,294
+2,377
+15% +$48.6K ﹤0.01% 1290
2024
Q4 		$300K Buy
15,917
+241
+2% +$4.98K ﹤0.01% 1337
2024
Q3 		$346K Buy
15,676
+338
+2% +$7.23K 0.01% 1037
2024
Q2 		$313K Buy
15,338
+1,364
+10% +$27.1K 0.01% 696
2024
Q1 		$281K Sell
13,974
-1,102
-7% -$21.2K 0.04% 382
2023
Q4 		$273K Buy
15,076
+194
+1% +$3.28K 0.07% 225
2023
Q3 		$253K Buy
14,882
+9
+0.1% +$167 0.12% 140
2023
Q2 		$284K Buy
14,873
+252
+2% +$4.75K 0.13% 139
2023
Q1 		$274K Buy
14,621
+241
+2% +$4.61K 0.13% 132
2022
Q4 		$285K Sell
14,380
-1,447
-9% -$28.5K 0.14% 131
2022
Q3 		$287K Buy
15,827
+258
+2% +$5.17K 0.17% 121
2022
Q2 		$310K Buy
15,569
+235
+2% +$4.92K 0.18% 117
2022
Q1 		$341K Buy
15,334
+229
+2% +$5.12K 0.19% 115
2021
Q4 		$387K Buy
15,105
+195
+1% +$4.68K 0.23% 98
2021
Q3 		$338K Buy
14,910
+198
+1% +$4.77K 0.21% 109
2021
Q2 		$340K Sell
14,712
-378
-3% -$8.68K 0.22% 106
2021
Q1 		$328K Buy
15,090
+217
+1% +$4.55K 0.24% 99
2020
Q4 		$303K Sell
14,873
-1,237
-8% -$23.6K 0.25% 97
2020
Q3 		$291K Buy
16,110
+269
+2% +$4.89K 0.3% 83
2020
Q2 		$282K Buy
15,841
+282
+2% +$4.98K 0.34% 79
2020
Q1 		$239K Buy
15,559
+309
+2% +$5.44K 0.37% 82
2019
Q4 		$291K Buy
15,250
+275
+2% +$4.98K 0.35% 97
2019
Q3 		$261K Buy
14,975
+287
+2% +$5.03K 0.34% 106
2019
Q2 		$262K Buy
14,688
+284
+2% +$4.87K 0.36% 93
2019
Q1 		$254K Sell
14,404
-831
-5% -$14.5K 0.36% 95
2018
Q4 		$241K Buy
+15,235
New +$270K 0.4% 90

Other funds holding THQ

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
HBCM
Heron Bay Capital Management Bloomfield Hills, Michigan $1.08B AUM 7.99% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

&Partners's THQ Position: Q1 2026 in Review

&Partners increased its abrdn Healthcare Opportunities Fund (THQ) stake by 27% in Q1 2026, buying an estimated $113K and bringing the position to 28,131 shares worth $473K. The position accounts for ﹤0.01% of the portfolio, ranked #1729.

&Partners first reported a position in THQ in Q4 2018 and has held it in 30 quarters since. 88 funds tracked by Wall St. Rank hold THQ as of Q1 2026.

  • &Partners held 28,131 shares of abrdn Healthcare Opportunities Fund worth $473K as of Q1 2026.
  • &Partners bought 5,993 abrdn Healthcare Opportunities Fund shares in Q1 2026, an estimated $113K.
  • abrdn Healthcare Opportunities Fund made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #1729 holding.
  • &Partners first reported a position in abrdn Healthcare Opportunities Fund in Q4 2018 and has held it in 30 quarters since.
  • 88 funds tracked by Wall St. Rank held abrdn Healthcare Opportunities Fund as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.